FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4377020446> ?p ?o ?g. }

• W4377020446 abstract "<b>Abstract ID 14356</b> <b>Poster Board 432</b> Diarrhea is a prevalent side effect of chemotherapeutic treatment that can result in reduction of quality of life, dose limitation, and death. Irinotecan is a widely used chemotherapeutic in the treatment of unresectable colorectal and metastatic triple-negative breast cancer. It produces both an acute cholinergic mediated diarrhea and a late onset diarrhea that has yet to be fully characterized. Treatment for the acute phase of diarrhea produced by irinotecan is treated with the muscarinic receptor antagonist atropine, however, late onset diarrhea is treated with the mu opioid receptor agonist loperamide. In a population of patients, however, diarrhea becomes refractory to treatment with loperamide. In this study we examine the role of cholinergic response in the development of tolerance to loperamide during late onset diarrhea. Previous reports have demonstrated that in a rodent model of irinotecan-induced diarrhea, choline acetyl transferase (ChAT) and vesicular acetylcholine transporter (VAChT) is increased in myenteric neurons. We hypothesize that enteric neurons become hyperexcitable following irinotecan treatment resulting in enhanced cholinergic activation precluding the efficacy of loperamide in the treatment of late onset diarrhea. In this study we measured neuronal excitability and nicotine-induced currents in isolated myenteric neurons from irinotecan-treated mice. Briefly male ICR mice were treated with 75 mg/kg irinotecan administered intra-peritoneally once daily for four consecutive days followed by monitoring and assessment of diarrhea for two additional days. On day 6 of our paradigm myenteric neurons were isolated and electrophysiological experiments were conducted to examine changes in basal properties. Animals treated with irinotecan produced a decrease in body weight over 6 days, increase in fecal water content, and time dependent increase in diarrhea scoring. We measured the electrophysiological properties of isolated myenteric neurons from irinotecan treated animals. There were no observed differences in resting membrane potentials of treated animals(fig D). Treated animals, however, produced a statistically significant increase in action potential amplitude 94.42 ± 3.03 mV (n=14) when compared to their controls 81.75 ± 3.489 mV (n=14) (P<0001 unpaired t-test) (fig A). Additionally, we found a decrease is the amount of current needed to elicit an action potential (Rheobase) in irinotecan treated animals 21.3 ± 3.065 pA as compared to their control 32 ± 4.047 pA (P<0.05 unpaired t-test) (fig B). In Irinotecan treated animals, nicotine inward currents were enhanced in a dose-dependent manner with maximal current at 1mM increased from -91.7 ± 12.21 pA/pF to -57.016 ± 7.426 pF/pA (n=5) (P<0.01 unpaired t-test) (fig C). Support/Funding Information: NIH-T32DA007027-47" @default.
• W4377020446 created "2023-05-19" @default.
• W4377020446 creator A5014342231 @default.
• W4377020446 creator A5030172543 @default.
• W4377020446 creator A5030189017 @default.
• W4377020446 date "2023-05-18" @default.
• W4377020446 modified "2023-09-29" @default.
• W4377020446 title "Enhanced Cholinergic Action of Myenteric Neurons During Chemotherapy Induced Diarrhea" @default.
• W4377020446 doi "https://doi.org/10.1124/jpet.122.143560" @default.
• W4377020446 hasPublicationYear "2023" @default.
• W4377020446 type Work @default.
• W4377020446 citedByCount "0" @default.
• W4377020446 crossrefType "proceedings-article" @default.
• W4377020446 hasAuthorship W4377020446A5014342231 @default.
• W4377020446 hasAuthorship W4377020446A5030172543 @default.
• W4377020446 hasAuthorship W4377020446A5030189017 @default.
• W4377020446 hasBestOaLocation W43770204461 @default.
• W4377020446 hasConcept C121608353 @default.
• W4377020446 hasConcept C126322002 @default.
• W4377020446 hasConcept C134018914 @default.
• W4377020446 hasConcept C204232928 @default.
• W4377020446 hasConcept C22885893 @default.
• W4377020446 hasConcept C2776907353 @default.
• W4377020446 hasConcept C2777573665 @default.
• W4377020446 hasConcept C2779802037 @default.
• W4377020446 hasConcept C2780259306 @default.
• W4377020446 hasConcept C526805850 @default.
• W4377020446 hasConcept C71924100 @default.
• W4377020446 hasConcept C90924648 @default.
• W4377020446 hasConcept C98274493 @default.
• W4377020446 hasConceptScore W4377020446C121608353 @default.
• W4377020446 hasConceptScore W4377020446C126322002 @default.
• W4377020446 hasConceptScore W4377020446C134018914 @default.
• W4377020446 hasConceptScore W4377020446C204232928 @default.
• W4377020446 hasConceptScore W4377020446C22885893 @default.
• W4377020446 hasConceptScore W4377020446C2776907353 @default.
• W4377020446 hasConceptScore W4377020446C2777573665 @default.
• W4377020446 hasConceptScore W4377020446C2779802037 @default.
• W4377020446 hasConceptScore W4377020446C2780259306 @default.
• W4377020446 hasConceptScore W4377020446C526805850 @default.
• W4377020446 hasConceptScore W4377020446C71924100 @default.
• W4377020446 hasConceptScore W4377020446C90924648 @default.
• W4377020446 hasConceptScore W4377020446C98274493 @default.
• W4377020446 hasLocation W43770204461 @default.
• W4377020446 hasOpenAccess W4377020446 @default.
• W4377020446 hasPrimaryLocation W43770204461 @default.
• W4377020446 hasRelatedWork W193685693 @default.
• W4377020446 hasRelatedWork W2008931489 @default.
• W4377020446 hasRelatedWork W2038765960 @default.
• W4377020446 hasRelatedWork W2098822886 @default.
• W4377020446 hasRelatedWork W2133106296 @default.
• W4377020446 hasRelatedWork W2136955408 @default.
• W4377020446 hasRelatedWork W2359599027 @default.
• W4377020446 hasRelatedWork W2370059930 @default.
• W4377020446 hasRelatedWork W270560386 @default.
• W4377020446 hasRelatedWork W2927870018 @default.
• W4377020446 isParatext "false" @default.
• W4377020446 isRetracted "false" @default.
• W4377020446 workType "article" @default.